Japanese

Sapporo Conference for Palliative and Supportive Care in Cancer Conference Organizer:Higashi Sapporo Hospital

  • Greeting

  • Board of Directors

    • Organization Committee
    • Senior Advisory Committee

  • Sapporo Conference2017

    • Greeting from Chair and Co-Chair
    • General Information
    • Program
    • To Chairs, Presenter, Moderator
    • Instruction for Participants
    • 一般演題募集要項
    • Access
    • Accommodation

  • Archives

    • 2014
    • 2017
    • 2023
  • Inquiry
  • Links


Greeting from Chair and Co-Chair

Ladies and gentlemen,

I am Masayoshi Kobune, a professor in the Department of Hematology at Sapporo Medical University School of Medicine. I am deeply honored to serve as the Chair of the 2026 Sapporo Conference for Palliative and Supportive Care in Cancer. First, I would like to express my heartfelt gratitude to all those considering participation in this event. I would also like to extend my sincere gratitude to everyone who has worked tirelessly to bring this conference to fruition.

The importance of palliative care in cancer medicine continues to grow. As healthcare professionals, we are entrusted with the responsibility to alleviate the pain and suffering of our patients and to maximize their quality of life (QOL). To fulfill this responsibility, we must continually deepen our understanding of palliative care and enhance our expertise in this essential field.

In recent years, cancer treatment has seen remarkable advancements, including the development of molecular targeted therapies and immunotherapies such as bispecific antibodies and CAR-T cell therapy. These innovations have expanded treatment possibilities even for elderly patients. With these advancements, patients' needs and concerns have become increasingly complex, further underscoring the significance of palliative care.

While providing practical palliative care, we strive to coexist with the disease through curative treatments and achieving complete cytogenetic remission. Nevertheless, there are times when we face challenges in navigating end-of-life care for patients with recurrent or refractory cases where a cure is not possible.

At this conference, we will explore critical topics in contemporary medicine, including "new cancer therapies and their integration with palliative care," "opioid management for cancer pain," and "ethical considerations in euthanasia and palliative care." By sharing insights with experts from around the world, we aim to discover new ways to provide better care for patients and their families.

I look forward to engaging with all of you at this conference and working together to pioneer new pathways in palliative and supportive care. I hope this event will be meaningful for each of you and serve as a valuable contribution to your clinical and research endeavors.

Masayoshi Kobune
Professor, Department of Hematology
Sapporo Medical University School of Medicine

TOP